Penetrium Bioscience Inc.
Research Penetrium Bioscience Inc. (187660.KQ) on Bullrun: market cap KRW 368.94B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker187660.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Care Facilities
- CurrencyKRW
- Market capKRW 368.94B
- Financial periodQ2 2026
- RevenueKRW 2.12B
- Net income-KRW 1.51B
- Free cash flow-KRW 1.70B
- Gross margin13.7%
Valuation Snapshot
latest market cap is KRW 368.94B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 368.94B | n/a | n/a | n/a |
Dividend history
About Penetrium Bioscience Inc.
Penetrium Bioscience Inc., a contract research organization, provides clinical-related professional services for customer requirements in South Korea. The company offers clinical development services, such as medical writing, clinical operation, late phase study, data management, biostatistics, and regulatory affairs.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Penetrium Bioscience Inc.'s market cap?
Penetrium Bioscience Inc.'s market capitalization is KRW 368.94B.
What does Penetrium Bioscience Inc. do?
Penetrium Bioscience Inc., a contract research organization, provides clinical-related professional services for customer requirements in South Korea. The company offers clinical development services, such as medical writing, clinical operation, late phase study, data management, biostatistics, and regulatory affairs. It also provides pharmacovigilance services, which include case processing and safety reporting, safety and risk management plans, aggregate reporting, literature screening, and medical device vigilance; and quality assurance services.